Oasmia Pharmaceutical AB Price on January 5, 2025

OASMYDelisted Stock  USD 0.06  0.00  0.00%   
If you're considering investing in Oasmia Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Oasmia Pharmaceutical stands at 0.06, as last reported on the 22nd of January, with the highest price reaching 0.06 and the lowest price hitting 0.06 during the day. We have found three technical indicators for Oasmia Pharmaceutical, which you can use to evaluate the volatility of the company.
  
Oasmia Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
OASMY
Based on monthly moving average Oasmia Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oasmia Pharmaceutical by adding Oasmia Pharmaceutical to a well-diversified portfolio.

Related Headline

American Vanguard Headline on 3rd of January 2025

Filed transaction by American Vanguard Officer See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Oasmia Pharmaceutical Valuation on January 5, 2025

It is possible to determine the worth of Oasmia Pharmaceutical on a given historical date. On January 5, 2025 Oasmia was worth 0.06 at the beginning of the trading date compared to the closed value of 0.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oasmia Pharmaceutical pink sheet. Still, in general, we apply an absolute valuation method to find Oasmia Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oasmia Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oasmia Pharmaceutical's related companies.
 Open High Low Close Volume
01/22/2025
  0.06    0.06    0.06    0.06    0.00  
Backtest Oasmia Pharmaceutical  |  Oasmia Pharmaceutical History  |  Oasmia Pharmaceutical Valuation 
Open Value
0.06
0.06
Closing Value
0.06
Upside

Oasmia Pharmaceutical Trading Date Momentum on January 5, 2025

Oasmia Pharmaceutical Fundamentals Correlations and Trends

By evaluating Oasmia Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oasmia Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oasmia financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oasmia Pharmaceutical Pink Sheet history

Oasmia Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oasmia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oasmia Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oasmia Pharmaceutical stock prices may prove useful in developing a viable investing in Oasmia Pharmaceutical
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden. Vivesto Ab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 17 people.

Oasmia Pharmaceutical Pink Sheet Technical Analysis

Oasmia Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Oasmia Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oasmia Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oasmia Pharmaceutical Period Price Range

Low
January 22, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Oasmia Pharmaceutical AB cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oasmia Pharmaceutical January 22, 2025 Market Strength

Market strength indicators help investors to evaluate how Oasmia Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oasmia Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Oasmia Pharmaceutical pink sheet market strength indicators, traders can identify Oasmia Pharmaceutical AB entry and exit signals to maximize returns
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Oasmia Pink Sheet

If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities